Improving graft survival for patients undergoing liver transplantation

Clinical Transplantation

Volumn 25, Issue 3, 2011, Pages

  Dickson, Rolland C ^a   Pungpapong, Surakit ^b   Keaveny, Andrew P ^b   Taner, C Burcin ^b   Ghabril, Marwan ^c   Aranda Michel, Jaime ^b   Satyanarayana, Raj ^b   Bonatti, Hugo ^d   Kramer, David J ^b   Nguyen, Justin H ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c INDIANA UNIVERSITY   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Hepatitis C; Liver transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CREATININE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BONE MARROW SUPPRESSION; CHRONIC GRAFT REJECTION; COMPARATIVE STUDY; CONTROLLED STUDY; DONOR; DRUG DOSE REDUCTION; DRUG INDUCED CANCER; DRUG SUBSTITUTION; DRUG WITHDRAWAL; END STAGE LIVER DISEASE; FEMALE; GASTROINTESTINAL SYMPTOM; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE DONORS; TREATMENT OUTCOME;

EID: 79958712591     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01428.x     Document Type: Article

References (30)

1. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002: 122: 889.
2. Thuluvath PJ, Krok KL, Segev DL, Yoo HY. Trends in post-liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States. Liver Transpl 2007: 13: 719.
3. Mutimer DJ, Gunson B, Chen J et al. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation 2006: 81: 7.
4. Machicao V, Bonatti H, Krishna M et al. Graft survival after liver transplantation is affected by donor age in hepatitis C related liver disease. Hepatology 2002: 60: 181A.
5. Machicao VI, Bonatti H, Krishna M et al. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 2004: 77: 84.
6. Feng S, Goodrich NP, Bragg-Gresham JL et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006: 6: 783.
7. Nguyen JH, Dickson RC, Harnois DM. A decade of liver transplantation at Mayo Clinic in Florida. Clin Transpl 2008: 127.
8. Harnois DM, Steers J, Andrews JC et al. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 1999: 5: 192.
9. Demetris A, Adams D, Bellamy C et al. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology 2000: 31: 792.
10. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997: 25: 658.
11. Ravaioli M, Grazi GL, Cescon M et al. Liver transplantations with donors aged 60years and above: the low liver damage strategy. Transpl Int 2009: 22: 423.
12. McCaughan GW, Shackel NA, Strasser SI, Dilworth P, Tang P. Minimal but significant improvement in survival for non-hepatitis C-related adult liver transplant patients beyond the one-year posttransplant mark. Liver Transpl 2010: 16: 130.
13. O'Leary JG, Randall H, Onaca N, Jennings L, Klintmalm GB, Davis GL. Post-liver transplant survival in hepatitis C patients is improving over time. Liver Transpl 2009: 15: 360.
14. Ghabril M, Dickson RC, Machicao VI et al. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival. Liver Transpl 2007: 13: 1717.
15. Berenguer M, Prieto M, San Juan F et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002: 36: 202.
16. Neumann UP, Berg T, Bahra M et al. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol 2004: 41: 830.
17. Burak KW, Kremers WK, Batts KP et al. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl 2002: 8: 362.
18. Wali M, Harrison RF, Gow PJ, Mutimer D. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002: 51: 248.
19. Russo MW, Galanko JA, Zacks SL, Beavers KL, Fried MW, Shrestha R. Impact of donor age and year of transplant on graft survival in liver transplant recipients with chronic hepatitis C. Am J Transplant 2004: 4: 1133.
20. Durand F, Renz JF, Alkofer B et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl 2008: 14: 1694.
21. Lake JR, Shorr JS, Steffen BJ, Chu AH, Gordon RD, Wiesner RH. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant 2005: 5: 549.
22. Rayhill SC, Wu YM, Katz DA et al. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. Transplantation 2007: 84: 331.
23. Valadao RM, Terrault NA. Older donors: mounting risks for the hepatitis C-infected liver transplant recipient? Liver Transpl 2009: 15: 677.
24. Data request October 9, 2009. United Network of Organ Sharing. 2009.
25. Segev DL, Maley WR, Simpkins CE et al. Minimizing risk associated with elderly liver donors by matching to preferred recipients. Hepatology 2007: 46: 1907.
26. Berenguer M. Risk of extended criteria donors in hepatitis C virus-positive recipients. Liver Transpl 2008: 14(Suppl 2): S45.
27. Begum R, Pungpapong S, Keaveny AP, Nguyen JH, Dickson RC. Outcome of liver transplantation (LT) for hepatitis C (HCV) using hepatitis B core antibody positive (anti-HBc+) graft. Hepatology 2009: 50(S4): A522.
28. Yataco ML, Dickson RC, Bonatti H et al. Dual hepatitis virus infections in liver transplant: case report and a review of the literature. Clin Transplant 2009: 23: 282.
29. Furukawa H, Todo S, Imventarza O et al. Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation 1991: 51: 1000.
30. Totsukali E, Fung JJ, Ishizawa Y et al. Synergistic effect of cold and warm ischemia time on postoperative graft outcome in human liver transplantation. Hepatogastroenterology 2004: 51: 1413.